Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513

Overview of attention for article published in BMC Cancer, November 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Trioxolane agents

Grant US-11072594-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.